{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T17:28:32Z","timestamp":1758475712058,"version":"3.37.3"},"reference-count":15,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1124\/dmd.117.076349","type":"journal-article","created":{"date-parts":[[2017,8,19]],"date-time":"2017-08-19T00:25:25Z","timestamp":1503102325000},"page":"1139-1145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Simple Evaluation Method for CYP3A4 Induction from Human Hepatocytes: The Relative Factor Approach with an Induction Detection Limit Concentration Based on the Emax Model"],"prefix":"10.1016","volume":"45","author":[{"given":"Shino","family":"Kuramoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5145-1774","authenticated-orcid":false,"given":"Motohiro","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetoshi","family":"Shindoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihisa","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Ishigai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Miyauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.117.076349_bib1","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1124\/dmd.109.027029","article-title":"In vitro and in vivo induction of cytochrome p450: a survey of the current practices and recommendations: a Pharmaceutical Research and Manufacturers of America perspective","volume":"37","author":"Chu","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.076349_bib2","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1517\/17425255.2010.516251","article-title":"Evaluation of models for predicting drug-drug interactions due to induction","volume":"6","author":"Fahmi","year":"2010","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/dmd.117.076349_bib3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1124\/dmd.107.017418","article-title":"HepaRG cells as an in vitro model for evaluation of cytochrome P450 induction in humans","volume":"36","author":"Kanebratt","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.076349_bib4","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3109\/00498254.2010.517277","article-title":"Prediction of clinical CYP3A4 induction using cryopreserved human hepatocytes","volume":"40","author":"Kaneko","year":"2010","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.117.076349_bib5","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3109\/00498250903184018","article-title":"In vitro model for the prediction of clinical CYP3A4 induction using HepaRG cells","volume":"39","author":"Kaneko","year":"2009","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.117.076349_bib6","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2133\/dmpk.20.236","article-title":"The quantitative prediction of in vivo enzyme-induction caused by drug exposure from in vitro information on human hepatocytes","volume":"20","author":"Kato","year":"2005","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.117.076349_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1124\/dmd.111.042259","article-title":"Simultaneous absolute protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases as a novel approach for the characterization of individual human liver: comparison with mRNA levels and activities","volume":"40","author":"Ohtsuki","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.076349_bib8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11095-005-8812-5","article-title":"Evaluation of human liver slices and reporter gene assays as systems for predicting the cytochrome p450 induction potential of drugs in vivo in humans","volume":"23","author":"Persson","year":"2006","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.117.076349_bib9","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1124\/dmd.106.010132","article-title":"Use of immortalized human hepatocytes to predict the magnitude of clinical drug-drug interactions caused by CYP3A4 induction","volume":"34","author":"Ripp","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.076349_bib10","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0022-3565(25)22379-5","article-title":"Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians","volume":"270","author":"Shimada","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.117.076349_bib11","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1124\/dmd.117.075481","article-title":"Quantitative prediction of CYP3A4 induction: impact of measured, free, and intracellular perpetrator concentrations from human hepatocyte induction studies on drug-drug interaction predictions","volume":"45","author":"Sun","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.076349_bib12","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1211\/jpp.61.05.0002","article-title":"Cytochrome P450-mediated metabolism in the human gut wall","volume":"61","author":"Thelen","year":"2009","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/dmd.117.076349_bib13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1124\/dmd.115.065581","article-title":"Evaluation of normalization methods to predict CYP3A4 induction in six fully characterized cryopreserved human hepatocyte preparations and HepaRG cells","volume":"44","author":"Vermet","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.076349_bib14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1124\/dmd.117.076349_bib15","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1124\/dmd.114.058602","article-title":"Evaluation of calibration curve-based approaches to predict clinical inducers and noninducers of CYP3A4 with plated human hepatocytes","volume":"42","author":"Zhang","year":"2014","journal-title":"Drug Metab Dispos"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624054059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624054059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.117.076349","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:30:29Z","timestamp":1739903429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624054059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0090955624054059"],"URL":"https:\/\/doi.org\/10.1124\/dmd.117.076349","relation":{},"ISSN":["0090-9556"],"issn-type":[{"type":"print","value":"0090-9556"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simple Evaluation Method for CYP3A4 Induction from Human Hepatocytes: The Relative Factor Approach with an Induction Detection Limit Concentration Based on the Emax Model","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.117.076349","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}